S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SABS SAB Biotherapeutics Inc

3.63

-0.24 (-6.20%)

After Hours

Last Updated: 08:05:11

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics (NASDAQ:SABS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more SAB Biotherapeutics Charts.

SAB Biotherapeutics Inc News

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
Monday 6 May 2024 (2 weeks ago) • GlobeNewswire Inc.

SAB Biotherapeutics Provides SAB-142 Trial Update
Tuesday 16 April 2024 (1 month ago) • GlobeNewswire Inc.

SAB Biotherapeutics to Present at INNODIA Annual Meeting
Monday 8 April 2024 (1 month ago) • GlobeNewswire Inc.

SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.

SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
Friday 29 March 2024 (2 months ago) • GlobeNewswire Inc.

SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
Tuesday 26 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 February 2024 (3 months ago) • Edgar (US Regulatory)

SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
Saturday 24 February 2024 (3 months ago) • GlobeNewswire Inc.

SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Friday 9 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

More SAB Biotherapeutics Inc News Articles

Quantify Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions